Whey Powder: FDA Inspects Compliance of Med Staff at 48 Hotels and 21 Outlets | Nagpur News

Nagpur: In the backdrop of the festive season, the Food and Drug Administration (FDA) has carried out checks at 48 restaurants and 21 chain outlets in the last few days, focusing on checking the medical fitness of their employees. “Remediation notices” have also been issued to organizations under the Food Safety and Standard Act. The FDA also destroyed more than 6,200 liters of milk and milk products on suspicion of adulteration with whey powder during its pre-Diwali campaign. TOI had earlier reported that the FDA destroyed 11 kg of khowa and mawa, which were used as raw materials in the preparation of sweets. Around 3,400 liters of allegedly adulterated edible oil was destroyed following raids at 13 locations in Itwari, Lakadganj, Sadar, Dharampeth and other markets. The FDA is enforcing a ban on the unfettered sale of edible oils. Officials also collected 47 samples of edible oil, 38 confectionery, 10 ghee and vanaspati and other food items. Authorities carried out inspections on a number of products on the instructions of joint commissioner Krishna Jaipurkar. Parameters such as hygiene, raw materials used, kitchen cleanliness, food quality. Staff have been checked for infectious diseases and such ailments.FDA deputy commissioner Prashant Deshmukh said restaurants and chain stores have been told to ensure their staff is medically fit to serve customers and maintain cleanliness and hygiene. “Improvement notices have been issued after the inspection, but if deficiencies are found in subsequent checks, actions will be initiated,” Deshmukh said. Jaipurkar stated that only packaged foods should be purchased from licensed owners during the festive season. “Edible food should be consumed as soon as possible and should not be kept in the refrigerator for more than a day,” Jaipurkar said, adding that hoteliers should be careful while serving customers during festivities.
We have also recently published the following articles

BKC restaurant issued notice to cease operations by Maharashtra FDA

Burn-Bar and Kitchen in Mumbai has been issued a cease-and-desist notice by the state Food and Drug Administration (FDA) for multiple hygiene violations. Violations include breaching license conditions, possession of expired products, the presence of synthetic food coloring and failure to properly distinguish between vegetarian and non-vegetarian products. The restaurant failed to provide the required records and analysis reports. The FDA has inspected nearly 200 restaurants since August, and 18 have been temporarily closed. An improvement notice was previously sent to Burn in March, but the necessary changes were not made.

FDA issues cease-and-desist notice to restaurant in BKC

Burn – Bar and Kitchen in Mumbai has been issued a cease-and-desist notice by the state Food and Drug Administration (FDA) for violations of hygiene standards. The FDA found numerous violations, including expired products, synthetic food coloring, and failure to properly differentiate between vegetarian and non-vegetarian products. Despite the notice, the restaurant was open for business. This is the 18th restaurant to be temporarily closed for hygiene violations since August. The FDA plans to revisit the restaurant.

US FDA approves Lilly’s weight-loss drug to compete with Novo’s Wegovy

The U.S. Food and Drug Administration has approved Eli Lilly’s weight-loss drug, allowing the company to enter the lucrative weight-loss market. The drug, called Zepbound, will be available in the United States by the end of the year. It was first approved for type 2 diabetes in 2022 under the name Mounjaro and has been used off-label for weight loss. Zepbound’s list price will be $1,059.87, which will be lower than Novo Nordisk’s rival drug Wegovy. The approval was based on a late-stage trial, and Zepbound’s side effects include nausea, diarrhea, hair loss and gastroesophageal reflux disease.